Serum calcification propensity predicts all-cause mortality in predialysis CKD

Journal of the American Society of Nephrology

Volumn 25, Issue 2, 2014, Pages 339-348

  Smith, Edward R ^a   Ford, Martin L ^b   Tomlinson, Laurie A ^c   Bodenham, Emma ^b   McMahon, Lawrence P ^a   Farese, Stefan ^d   Rajkumar, Chakravarthi ^b   Holt, Stephen G ^a,e   Pasch, Andreas ^d  

^a MONASH UNIVERSITY   (Australia)

^b ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

^d UNIVERSITY OF BERN   (Switzerland)

^e ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FETUIN A; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PHOSPHATE; PYROPHOSPHATE; VITAMIN D;

ADULT; AGED; ALBUMIN BLOOD LEVEL; AORTA; ARTERIAL STIFFNESS; ARTERY CALCIFICATION; ARTICLE; BLOOD CHEMISTRY; BONE; CALCIUM BLOOD LEVEL; CARDIOVASCULAR FUNCTION; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; DIAGNOSTIC TEST; DISEASE SEVERITY; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; OSTEOBLAST; PHOSPHATE BLOOD LEVEL; PRECIPITATION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROPENSITY SCORE; PROSPECTIVE STUDY; PULSE WAVE; RENAL REPLACEMENT THERAPY; RISK FACTOR; SERUM; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALPHA-2-HS-GLYCOPROTEIN; ARTERIOSCLEROSIS; BIOLOGICAL MARKERS; CALCINOSIS; CALCIUM PHOSPHATES; CARDIOVASCULAR DISEASES; CAUSALITY; COMORBIDITY; DIABETES MELLITUS; DIPHOSPHATES; DISEASE SUSCEPTIBILITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MORTALITY; OSTEOCLASTS; PHOSPHATES; PROSPECTIVE STUDIES; PULSE WAVE ANALYSIS; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; RISK; SERUM ALBUMIN; SMOKING; VASCULAR RESISTANCE;

EID: 84893502491     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013060635     Document Type: Article

References (32)

1. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM: Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 38:938-942, 2001
2. Monckeberg JG: Über die reine Mediaverkalkung der Extremitätenarterien und ihr Verhalten zur Arteriosklerose. Virchows ArchAPathol Anat Histol 171:141-167, 1903
3. London GM, Pannier B, Marchais SJ: Vascular calcifications, arterial aging and arterial remodeling in ESRD. Blood Purif 35:16-21, 2013
4. Guérin AP, London GM, Marchais SJ, Metivier F: Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 15:1014-1021, 2000
5. O'Rourke MF: Arterial aging: Pathophysiological principles. Vasc Med 12:329-341, 2007
6. Mitchell GF: Arterial stiffness and wave reflection: Biomarkers of cardiovascular risk. Artery Res 3:56-64, 2009
7. Shroff R, Long DA, Shanahan C: Mechanistic insights into vascular calcification in CKD. J Am Soc Nephrol 24:179-189, 2013
8. Shanahan CM, Cary NR, Salisbury JR, Proudfoot D, Weissberg PL, Edmonds ME: Medial localization of mineralization-regulating proteins in association with Mönckeberg's sclerosis: Evidence for smooth muscle cell-mediated vascular calcification. Circulation 100:2168-2176, 1999
9. Smith ER, Hanssen E, McMahon LP, Holt SG: Fetuin-A-containing calciprotein particles reduce mineral stress in the macrophage. PLoS One 8:e60904, 2013
10. Jahnen-Dechent W, Heiss A, Schäfer C, Ketteler M: Fetuin-Aregulation of calcified matrix metabolism. Circ Res 108:1494-1509, 2011
11. Hamano T, Matsui I, Mikami S, Tomida K, Fujii N, Imai E, Rakugi H, Isaka Y: Fetuin-mineral complex reflects extraosseous calcification stress in CKD. J Am Soc Nephrol 21:1998-2007, 2010
12. Smith ER, Ford ML, Tomlinson LA, Rajkumar C, McMahon LP, Holt SG: Phosphorylated fetuin-A-containing calciprotein particles are associated with aortic stiffness and a procalcific milieu in patients with predialysis CKD. Nephrol Dial Transplant 27:1957-1966, 2012
13. Pasch A, Farese S, Gräber S, Wald J, Richtering W, Floege J, Jahnen-Dechent W: Nanoparticle-based test measures overall propensity for calcification in serum. J Am Soc Nephrol 23:1744-1752, 2012
14. Fraser CG, Harris EK: Generation and application of data on biological variation in clinical chemistry. Crit Rev Clin Lab Sci 27:409-437, 1989
15. Jahnen-Dechent W, Schäfer C, Heiss A, Grötzinger J: Systemic inhibition of spontaneous calcification by the serum protein alpha 2-HS glycoprotein/fetuin. Z Kardiol 90 [Suppl 3]: 47-56, 2001
16. O'Neill WC, Lomashvili KA, Malluche HH, Faugere MC, Riser BL: Treatment with pyrophosphate inhibits uremic vascular calcification. Kidney Int 79:512-517, 2011
17. Louvet L, Büchel J, Steppan S, Passlick-Deetjen J, Massy ZA: Magnesium prevents phosphate-induced calcification in human aortic vascular smooth muscle cells. Nephrol Dial Transplant 28:869-878, 2013
18. Shanahan CM, Crouthamel MH, Kapustin A, Giachelli CM: Arterial calcification in chronic kidney disease: Key roles for calcium and phosphate. Circ Res 109:697-711, 2011
19. Toussaint ND, Lau KK, Strauss BJ, Polkinghorne KR, Kerr PG: Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease. Nephrol Dial Transplant 23:586-593, 2008
20. Toussaint ND, Lau KK, Strauss BJ, Polkinghorne KR, Kerr PG: Relationship between vascular calcification, arterial stiffness and bone mineral density in a cross-sectional study of prevalent Australian haemodialysis patients. Nephrology (Carlton) 14:105-112, 2009
21. London GM, Marchais SJ, Guérin AP, Boutouyrie P, Métivier F, de Vernejoul MC: Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD. J Am Soc Nephrol 19:1827-1835, 2008
22. Tintut Y, Patel J, Parhami F, Demer LL: Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation 102:2636-2642, 2000
23. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, Pannier B, Vlachopoulos C, Wilkinson I, Struijker-Boudier H; European Network for Non-Invasive Investigation of Large Arteries: Expertconsensusdocumentonarterialstiffness: Methodological issues and clinical applications. Eur Heart J 27:2588-2605, 2006
24. Raggi P, Bellasi A, Ferramosca E, Islam T, Muntner P, Block GA: Association of pulse wave velocity with vascular and valvular calcification in hemodialysis patients. Kidney Int 71:802-807, 2007
25. Sigrist MK, Taal MW, Bungay P, McIntyre CW: Progressive vascular calcification over 2 years is associated with arterial stiffening and increasedmortality in patients with stages4 and 5 chronickidney disease. Clin J Am Soc Nephrol 2:1241-1248, 2007
26. McEniery CM, McDonnell BJ, So A, Aitken S, Bolton CE, Munnery M, Hickson SS, Yasmin, Maki-Petaja KM, Cockcroft JR, Dixon AK, Wilkinson IB; Anglo-Cardiff Collaboration Trial Investigators: Aortic calcification is associated with aortic stiffness and isolated systolic hypertension in healthy individuals. Hypertension 53:524-531, 2009
27. Karras A, Haymann JP, Bozec E, Metzger M, Jacquot C, Maruani G, Houillier P, Froissart M, Stengel B, Guardiola P, Laurent S, Boutouyrie P, Briet M; Nephro Test Study Group: Large artery stiffening and remodeling are independently associated with all-cause mortality and cardiovascular events in chronic kidney disease. Hypertension 60:1451-1457, 2012
28. Smith ER, Tomlinson LA, Ford ML, McMahon LP, Rajkumar C, Holt SG: Elastin degradation is associated with progressive aortic stiffening and all-cause mortality in predialysis chronic kidney disease. Hypertension 59:973-978, 2012
29. Ford ML, Tomlinson LA, Chapman TP, Rajkumar C, Holt SG: Aortic stiffness is independently associated with rate of renal function decline in chronic kidneydiseasestages3and4. Hypertension 55:1110-1115, 2010
30. Benetos A, Adamopoulos C, Bureau JM, Temmar M, Labat C, Bean K, Thomas F, Pannier B, Asmar R, Zureik M, Safar M, Guize L: Determinants of accelerated progression of arterial stiffness in normotensive subjects and in treated hypertensive subjects over a 6-year period. Circulation 105:1202-1207, 2002
31. De Long ER, De Long DM, Clarke-Pearson DL: Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics 44:837-845, 1988
32. Ockene IS, Matthews CE, Rifai N, Ridker PM, Reed G, Stanek E: Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults. Clin Chem 47:444-450, 2001